ILD-PRO Trademark

Trademark Overview


On Wednesday, October 3, 2018, a trademark application was filed for ILD-PRO with the United States Patent and Trademark Office. The USPTO has given the ILD-PRO trademark a serial number of 88141447. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, January 8, 2026. This trademark is owned by Boehringer Ingelheim Pharmaceuticals, Inc.. The ILD-PRO trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical and pharmaceutical information regarding interstitial lung diseases, their symptoms, prevention and treatment, and medical information regarding biomarker testing relating thereto

Maintaining a registry of patients with interstitial lung diseases; promoting awareness of interstitial lung diseases, their symptoms, prevention and treatment, and promoting awareness of biomarker testing therefor
ild-pro

General Information


Serial Number88141447
Word MarkILD-PRO
Filing DateWednesday, October 3, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, January 8, 2026
Registration Number6086392
Registration DateTuesday, June 23, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 5, 2019

Trademark Statements


Goods and ServicesProviding medical and pharmaceutical information regarding interstitial lung diseases, their symptoms, prevention and treatment, and medical information regarding biomarker testing relating thereto
Goods and ServicesMaintaining a registry of patients with interstitial lung diseases; promoting awareness of interstitial lung diseases, their symptoms, prevention and treatment, and promoting awareness of biomarker testing therefor
Description of MarkThe mark consists of a swirl design in blue and white to the left the wording "ILD-PRO", with "ILD" in dark blue and "PRO" in light blue and the dash between "ILD" and "PRO" in light blue
Indication of Colors claimedThe color(s) dark blue, light blue and white is/are claimed as a feature of the mark.
Pseudo MarkINTERSTITIAL LUNG DISEASES PRO

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, October 12, 2018
Primary Code035
First Use Anywhere DateTuesday, April 30, 2019
First Use In Commerce DateTuesday, April 30, 2019

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 12, 2018
Primary Code044
First Use Anywhere DateTuesday, April 30, 2019
First Use In Commerce DateTuesday, April 30, 2019

Trademark Owner History


Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Trademark Events


Event DateEvent Description
Saturday, October 6, 2018NEW APPLICATION ENTERED
Friday, October 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 13, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 15, 2019ASSIGNED TO EXAMINER
Tuesday, January 15, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 15, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, January 15, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 15, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, January 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 30, 2019ASSIGNED TO LIE
Wednesday, February 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 5, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 30, 2019TEAS STATEMENT OF USE RECEIVED
Saturday, September 21, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 30, 2019USE AMENDMENT FILED
Wednesday, September 25, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 22, 2019SU - NON-FINAL ACTION - WRITTEN
Tuesday, October 22, 2019NON-FINAL ACTION E-MAILED
Tuesday, October 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 28, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, April 22, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 23, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 15, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, May 16, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 23, 2020REGISTERED-PRINCIPAL REGISTER
Monday, June 23, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 1, 2025TEAS SECTION 8 & 15 RECEIVED
Thursday, January 8, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 8, 2026REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 8, 2026NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED